Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Inhibitors of protein kinase GSK3 prepared at Chiron, U. of California

July 8, 1998

Phase Ia clinical trial with NIF for ischemic stroke completed by Pfizer

July 7, 1998

CNS-selective effects of synthetic, nonfeminizing estrogens

July 7, 1998

New antimigraine option now available in Canada

July 7, 1998

Ganaxolone study results presented at AASH meeting

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

July 7, 1998

S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats

July 6, 1998

CNI-1493 treatment associated with improvement in mouse model of MS

July 6, 1998

Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia

July 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...